Laboratory of Endocrinology, Department of Bioscience Barkatullah University Bhopal, Madhya Pradesh, India.
Department of Bioresources, University of Kashmir, Srinagar, Jammu and Kashmir, India.
Front Endocrinol (Lausanne). 2023 Aug 21;14:1153289. doi: 10.3389/fendo.2023.1153289. eCollection 2023.
Polycystic Ovary syndrome (PCOS) affects the health of many women around theworld. Apart from fundamental metabolic problems connected to PCOS, focus of our study is on the role of quercetin on genes relevant to steroidogenesis and folliculogenesis.
Eighteen mature parkes strain mice (4-5 weeks old) weighing18-21 g were randomly divided into three groups of six each as follows: Group I serves as the control and was given water and a regular chow diet ad lib for 66 days; group II was given oral gavage administration of letrozole (LETZ) (6 mg/kgbw) for 21 days to induce PCOS and was left untreated for 45 days; For three weeks, Group III received oral gavage dose of LETZ (6 mg/kg), after which it received Quercetin (QUER) (125 mg/kg bw orally daily) for 45 days.
In our study we observed that mice with PCOS had irregular estrous cycle with increased LH/FSH ratio, decreased estrogen level and decline in expression of Kitl, Bmp1, Cyp11a1, Cyp19a1, Ar, lhr, Fshr and Esr1 in ovary. Moreover, we observed increase in the expression of CYP17a1, as well as increase in cholesterol, triglycerides, testosterone, vascular endothelial growth factor VEGF and insulin levels. All these changes were reversed after the administration of quercetin in PCOS mice.
Quercetin treatment reversed the molecular, functional and morphological abnormalities brought on due to letrozole in pathological and physiological setting, particularly the issues of reproduction connected to PCOS. Quercetin doesn't act locally only but it acts systematically as it works on Pituitary (LH/FSH)- Ovary (gonad hormones) axis. the Side effects of Quercetin have to be targeted in future researches. Quercetin may act as a promising candidate for medical management of human PCOS.
多囊卵巢综合征(PCOS)影响着全世界许多女性的健康。除了与 PCOS 相关的基本代谢问题外,我们的研究重点还在于槲皮素对与类固醇生成和卵泡发生相关的基因的作用。
将 18 只成熟的 Parkes 品系小鼠(4-5 周龄,体重 18-21g)随机分为三组,每组 6 只:第 I 组作为对照组,给予水和常规饲料自由饮食 66 天;第 II 组给予来曲唑(LETZ)(6mg/kgbw)口服灌胃 21 天诱导 PCOS,然后不治疗 45 天;第 III 组连续 3 周给予 LETZ(6mg/kg)口服灌胃,然后给予槲皮素(QUER)(125mg/kgbw 每日口服)45 天。
在我们的研究中,我们观察到 PCOS 小鼠的动情周期不规则,LH/FSH 比值升高,雌激素水平降低,卵巢中 Kitl、Bmp1、Cyp11a1、Cyp19a1、Ar、lhr、Fshr 和 Esr1 的表达下降。此外,我们观察到 CYP17a1 的表达增加,以及胆固醇、甘油三酯、睾酮、血管内皮生长因子 VEGF 和胰岛素水平升高。所有这些变化在 PCOS 小鼠给予槲皮素后均得到逆转。
槲皮素治疗逆转了在病理生理环境下由于来曲唑引起的分子、功能和形态异常,特别是与 PCOS 相关的生殖问题。槲皮素不仅局部起作用,而且系统起作用,因为它作用于垂体(LH/FSH)-卵巢(性腺激素)轴。在未来的研究中需要针对槲皮素的副作用进行研究。槲皮素可能是治疗人类 PCOS 的有前途的候选药物。